Clinical Trial Update: Glutamate Reducing Interventions in Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating glutamate-reducing interventions for individuals at clinical high risk for psychosis; study completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinical High Risk For Psychosis

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Clinical High Risk for Psychosis | Phase 1 | Status: COMPLETED | Results posted: 2021-12-01